Antibody Drug Conjugate Market Share, Size, Key Players, Trends, Competitive And Regional Forecast To 2030
Research Reports
Aug 17, 2023
Antibody Drug Conjugate Market Research Report Information By Type (Monoclonal Antibodies, Linker), By Product (Adcertis, Kadcyla), By Technology (Immunogen Technology, Immunomedics Technology), By Applications (Leukemia, Lymphoma), By End-Users (Biotechnology Companies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.
The antibody drug conjugate market size was valued at USD 1.98 billion in 2021 and is projected to grow from USD 2.31 Billion in 2022 to USD 6.81 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.70% during the forecast period (2022 – 2030)Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, multiple myeloma, breast cancer, solid tumors, skin cancer, ovary cancer, colon cancer, lung cancer, glioblastoma, pancreas cancer, kidney cancer, prostate cancer, leukemia, and others are some of its key applications. The different antibody drug conjugates include drug/toxin, linker, and monoclonal antibodies, to name a few.
Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research.
On the contrary, shortage of funds & high procedure prices are factors that are likely to impede the global antibody drug conjugate market growth during the forecast period.
Get Free Sample PDF Brochure @
https://www.marketresearchfuture.com/sample_request/1113
Market Segmentation
The MRFR report provides an inclusive segmental analysis of the antibody drug conjugate market by end user, application, technology, product, and type.
Based on type, the antibody drug conjugate market has been segmented into drug/toxin, linker, monoclonal antibodies, & other types.
Based on application, the market for antibody drug conjugate has been segmented into solid tumors, skin, lymphoma, multiple myeloma, cancer, colon cancer, lung cancer, glioblastoma, ovary cancer, pancreas cancer, kidney cancer, prostate cancer, leukemia, and others. The leukemia segment is again segmented into chronic lymphocytic leukemia (CLL), acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), acute myeloid leukemia (AML), and others.
By product, the antibody drug conjugate market has been segmented into adcertis, kadcyla, & other products.
By technology, the global antibody drug conjugate market has been segmented into ImmunoGen technology, immunomedics technology, Seattle genetics technology, and others.
By end user, the antibody drug conjugate market is segmented into biopharmaceutical companies, biotechnology companies, academic research institutes, specialized cancer centers, hospitals, and others.
Competitive Analysis
Leading antibody drug conjugate companies profiled in the global antibody drug conjugate market report include Vaccinex Inc (U.S.), Antikor (U.K), Agensys, Inc. (U.S.), Concortis Biotherapeutics (U.S.), Genentech (U.S.), Roche Holding AG (Switzerland), ImmunoGen, Inc.(U.S.), and Seattle Genetics (U.S.). Industry players have implemented different strategies such as acquisitions, mergers, extensive R&D, joint ventures, partnerships, strategic alliances, and new product launches to stay ahead in the competition and also cater to the growing needs of the customers.
Regional Analysis
Based on the region, the global antibody drug conjugate market covers the recent trends and growth opportunities across Europe, the Asia Pacific (APAC), the Americas, and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market over the forecast period for increasing healthcare awareness and rising prevalence of cancer.
Browse In-depth Market Research Report (140 Pages) on Antibody Drug Conjugate:
https://www.marketresearchfuture.com/reports/antibody-drug-conjugate-market-1113
The antibody drug conjugate market in Europe is predicted to have healthy growth over the forecast period for the huge population being affected by cancer. Besides, the government is focussing on R&D to develop new drugs to offer citizens the best treatment.
The antibody drug conjugate market in the APAC region is predicted to grow at a fast rate over the forecast period due to increasing prevalence of cancer in India & China.
Discover More Research Reports on Healthcare Industry by Market Research Future
The antibody drug conjugate market in the MEA is predicted to have steady growth over the forecast period.
India CRO Market Research Report: Information By Service Type (Clinical Trials, Product Development, Process Development, Post-Marketing Surveillance, and Quality Monitoring Others), By Therapeutic Application (Oncology, Cardiovascular, Neurology, Nephrology and Urology, and Others), By End User (Pharmaceutical/Biopharmaceutical Companies, Medical Devices Companies, and Academic Institutes), and By Region (India) – Market Forecast Till 2032
Hirsutism Treatment Market Research Report Information, By Type (Idiopathic Hirsutism, Secondary Hirsutism, and others), By Diagnosis (Blood Tests, Imaging Tests, Physical Examination), By Treatment (Medications, Procedures, and others), By End User- Global Forecast Till 2030
Dermal Fillers Market Research Report Information By Type (Hyaluronic Acid, Polymers & Particles, Calcium Hydroxylapatite, and Collagen), By Application (Facial Line Correction Treatment, Face-Lift, and Lip Treatments), By Brands (Juvederm, Radiesse, and Restylane) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Follow Us: LinkedIn | Twitter
Contact Information:
Contact: Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com
Tags:
Wire, Research Newswire, English